Want to see IN:KRSNAA full AI Analyst Report?

Krsnaa Diagnostics Limited (KRSNAA) Price & Analysis

1 Followers

KRSNAA Stock Chart & Stats

₹559.25

-₹2.45(-0.45%)

At close: Jul 27 4:00 PM EDT

₹559.25

-₹2.45(-0.45%)

Day’s Range― - ―

52-Week Range₹502.20 - ₹849.05

Previous CloseN/A

Volume72.45K

Average Volume (3M)9.43K

Market Cap

₹18.14B

Enterprise Value₹18.85B

Total Cash (Recent Filing)₹3.61B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)18.4

Beta0.93

Next Earnings

Nov 14, 2026

EPS Estimate

5.1

Next Dividend Ex-DateN/A

Dividend Yield0.36%

Share Statistics

EPS (TTM)30.04

Shares Outstanding32,438,670

10 Day Avg. Volume3,839

30 Day Avg. Volume9,426

Financial Highlights & Ratios

PEG Ratio0.55

Price to Book (P/B)1.72

Price to Sales (P/S)2.18

P/FCF Ratio-17.89

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)38.47

Revenue Forecast (FY)₹10.02B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained revenue expansion indicates continued demand for pathology and imaging services. Growth across several years supports operating scale, broader patient access and stronger utilization potential beyond a single reporting period.

Deleveraged Balance SheetLower leverage improves financial resilience and reduces funding pressure as the company expands diagnostic capacity. The stronger equity base also provides more flexibility to absorb investment needs or operating volatility.

Positive Operating Cash FlowPositive operating cash generation shows that core diagnostic operations are producing cash to support day-to-day activity. This provides an internal funding base, even though expansion spending and working capital limit free cash flow.

Bears Say

Persistently Negative Free Cash FlowRepeatedly negative free cash flow indicates that investment requirements or working-capital needs consume operating cash. If sustained, expansion may require additional funding and could constrain financial flexibility despite the improved balance sheet.

Volatile ProfitabilityProfit volatility makes earnings less predictable and complicates long-term planning. Inconsistent margins may reflect changing service mix, pricing or operating costs, limiting confidence that recent earnings recovery will remain durable.

Weak Cash ConversionWeak cash conversion reduces the quality of reported earnings because profits are not consistently translating into liquidity. This can increase reliance on balance-sheet capacity or external funding to finance ongoing operations and growth.

Krsnaa Diagnostics Limited News

Krsnaa Diagnostics Wins Shareholder Nod for Promoter-Backed Warrant Issue

The latest update is out from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ). Krsnaa Diagnostics Limited has secured shareholder...

19d ago

Krsnaa Diagnostics Announces Dispatch of Annual Report and AGM Notice

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an announcement. Krsnaa Diagnostics Limited has completed the dispatch of...

1M ago

Krsnaa Diagnostics Clears Q1 Results, Sets AGM and Approves Promoter Warrants Issue

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics Limited’s board approved the unaudited standalone...

2M ago

Krsnaa Diagnostics Posts 22% Revenue Growth as Rajasthan Network Goes Live and Promoters Back Expansion

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics reported a 22% year-on-year rise in...

2M ago

Krsnaa Diagnostics Releases Investor Presentation on Q1 FY2026-27 Results

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has issued an update. Krsnaa Diagnostics Limited has released an investor and...

2M ago

Krsnaa Diagnostics Posts Record Profit and Accelerates Retail Expansion in FY2026

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an update. Krsnaa Diagnostics reported its highest-ever consolidated profit after...

5M ago

Krsnaa Diagnostics Releases Investor Presentation on FY2026 Results

An announcement from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) is now available. Krsnaa Diagnostics has released an investor...

5M ago

Krsnaa Diagnostics overhauls board and finance leadership in governance revamp

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics has moved to overhaul its leadership...

6M ago

Krsnaa Diagnostics Shareholders Clear Five-Year Reappointment of Executive Chairman

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an announcement. Krsnaa Diagnostics Limited has secured shareholder approval via...

6M ago

Krsnaa Diagnostics Shareholders Approve Re-Appointment of Executive Chairman

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has issued an update. Krsnaa Diagnostics Limited has secured shareholder approval via...

6M ago

KRSNAA FAQ

What was Krsnaa Diagnostics Limited’s price range in the past 12 months?

Krsnaa Diagnostics Limited lowest stock price was ₹502.20 and its highest was ₹849.05 in the past 12 months.

What is Krsnaa Diagnostics Limited’s market cap?

Krsnaa Diagnostics Limited’s market cap is ₹18.14B.

When is Krsnaa Diagnostics Limited’s upcoming earnings report date?

Krsnaa Diagnostics Limited’s upcoming earnings report date is Nov 14, 2026 which is in 37 days.

How were Krsnaa Diagnostics Limited’s earnings last quarter?

Krsnaa Diagnostics Limited released its earnings results on Aug 13, 2026. The company reported ₹5.15 earnings per share for the quarter, missing the consensus estimate of ₹6.15 by -₹1.

Is Krsnaa Diagnostics Limited overvalued?

According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Krsnaa Diagnostics Limited pay dividends?

Krsnaa Diagnostics Limited pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.36%. See more information on Krsnaa Diagnostics Limited dividends here

What is Krsnaa Diagnostics Limited’s EPS estimate?

Krsnaa Diagnostics Limited’s EPS estimate is 5.1.

How many shares outstanding does Krsnaa Diagnostics Limited have?

Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.

What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?

Krsnaa Diagnostics Limited reported an EPS of ₹5.15 in its last earnings report, missing expectations of ₹6.15. Following the earnings report the stock price went down -4.013%.

Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?

Currently, no hedge funds are holding shares in IN:KRSNAA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers mammography, stress tests, dual-energy X-ray absorptiometry scans, bone mineral density tests, computed tomography scans, and magnetic resonance imaging services, as well as tele-radiology and tele-pathology services. The company was incorporated in 2010 and is based in Pune, India.